Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop.

Newman JH, Fanburg BL, Archer SL, Badesch DB, Barst RJ, Garcia JG, Kao PN, Knowles JA, Loyd JE, McGoon MD, Morse JH, Nichols WC, Rabinovitch M, Rodman DM, Stevens T, Tuder RM, Voelkel NF, Gail DB, National Heart, Lung and Blood Institute/Office of Rare Diseases
Circulation. 2004 109 (24): 2947-52

PMID: 15210611 · DOI:10.1161/01.CIR.0000132476.87231.6F

MeSH Terms (20)

Adult Animals Arginine Bone Morphogenetic Protein Receptors, Type II Enzyme Inhibitors Female Forecasting Genetic Predisposition to Disease Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors Hypertension, Pulmonary Male Models, Biological Pancreatic Elastase Platelet Aggregation Inhibitors Potassium Channels Protein-Serine-Threonine Kinases Rats Research Signal Transduction

Connections (1)

This publication is referenced by other Labnodes entities:

Links